Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab

Guardado en:

Detalles Bibliográficos
Autores principales:	Jacob D. Siegel, MD, Aarti Bhatia, MD, MPH, Christine J. Ko, MD, Sean R. Christensen, MD, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	cemiplimab cSCC cutaneous squamous cell carcinoma immune checkpoint inhibitor immunotherapy locally advanced Dermatology RL1-803
Acceso en línea:	https://doaj.org/article/00637970d09a41649c0ae007b9b72dcc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:00637970d09a41649c0ae007b9b72dcc
record_format	dspace
spelling	oai:doaj.org-article:00637970d09a41649c0ae007b9b72dcc2021-11-04T04:32:47ZConcurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab2352-512610.1016/j.jdcr.2021.10.009https://doaj.org/article/00637970d09a41649c0ae007b9b72dcc2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352512621007335https://doaj.org/toc/2352-5126Jacob D. Siegel, MDAarti Bhatia, MD, MPHChristine J. Ko, MDSean R. Christensen, MD, PhDElsevierarticlecemiplimabcSCCcutaneous squamous cell carcinomaimmune checkpoint inhibitorimmunotherapylocally advancedDermatologyRL1-803ENJAAD Case Reports, Vol 18, Iss , Pp 23-25 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	cemiplimab cSCC cutaneous squamous cell carcinoma immune checkpoint inhibitor immunotherapy locally advanced Dermatology RL1-803
spellingShingle	cemiplimab cSCC cutaneous squamous cell carcinoma immune checkpoint inhibitor immunotherapy locally advanced Dermatology RL1-803 Jacob D. Siegel, MD Aarti Bhatia, MD, MPH Christine J. Ko, MD Sean R. Christensen, MD, PhD Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
format	article
author	Jacob D. Siegel, MD Aarti Bhatia, MD, MPH Christine J. Ko, MD Sean R. Christensen, MD, PhD
author_facet	Jacob D. Siegel, MD Aarti Bhatia, MD, MPH Christine J. Ko, MD Sean R. Christensen, MD, PhD
author_sort	Jacob D. Siegel, MD
title	Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_short	Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_full	Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_fullStr	Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_full_unstemmed	Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_sort	concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/00637970d09a41649c0ae007b9b72dcc
work_keys_str_mv	AT jacobdsiegelmd concurrentdevelopmentofhighstagecutaneoussquamouscellcarcinomaduringcompleteresponseofmetastaticcutaneoussquamouscellcarcinomatoprogrammedcelldeathprotein1blockadewithcemiplimab AT aartibhatiamdmph concurrentdevelopmentofhighstagecutaneoussquamouscellcarcinomaduringcompleteresponseofmetastaticcutaneoussquamouscellcarcinomatoprogrammedcelldeathprotein1blockadewithcemiplimab AT christinejkomd concurrentdevelopmentofhighstagecutaneoussquamouscellcarcinomaduringcompleteresponseofmetastaticcutaneoussquamouscellcarcinomatoprogrammedcelldeathprotein1blockadewithcemiplimab AT seanrchristensenmdphd concurrentdevelopmentofhighstagecutaneoussquamouscellcarcinomaduringcompleteresponseofmetastaticcutaneoussquamouscellcarcinomatoprogrammedcelldeathprotein1blockadewithcemiplimab
_version_	1718445250530246656

Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab

Ejemplares similares